TLE4 and breast carcinoma: The next step was to verify whether APH1A, CTBP1, DTX1, HEY1, HEY2, JAG2, NOTCH4, TLE2, and TLE4 could be targets of miRNAs that differentiate breast cancer from the control (Table 5).